Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human articular chondrocytes

Clinical and Experimental Rheumatology

Volumn 25, Issue 4, 2007, Pages 605-612

  Simopoulou, Theodora ^a   Malizos, Konstantinos N ^a   Tsezou, Aspasia ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Cartilage; Chondrocytes; LOX 1 expression; Osteoarthritis

Indexed keywords

ASCORBIC ACID; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; RETINOIC ACID RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LIPOPROTEIN BLOOD LEVEL; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIAL FLUID LEVEL;

AGED; AGED, 80 AND OVER; ASCORBIC ACID; CARTILAGE, ARTICULAR; CELL SURVIVAL; CHONDROCYTES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OSTEOARTHRITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS E; SYNOVIAL FLUID;

EID: 34648813473     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. MEHTA JL, CHEN J, HERMONAT PL, ROMEO F, NOVELLI G: Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 2006; 69: 36-45.
2. RUTSCH F, TERKELTAUB R: Deficiencies of physiologic calcification inhibitors and low-grade inflammation in arterial calcification: Lessons for cartilage calcification. Joint Bone Spine 2005; 72: 110-18.
3. STOCKWELL RA: Lipid in the matrix of aging articular cartilage. Nature 1965; 207: 427-8.
4. LIPPIELLO L, WALSH T, FIENHOLD M: The association of lipid abnormalities with tissue pathology in human osteoarthritic articular cartilage. Metabolism 1991; 40: 571-6.
5. KELLGREN JH: Osteoarthrosis in patients and populations. BMJ 1961; 1: 1-6.
6. HART DJ, DOYLE DV, SPECTOR TD: Association between metabolic factors and knee osteoarthritis in women: The Chingford Study. J Rheumatol 1995; 22: 1118-23.
7. STÜRMER T, SUN Y, SAUERLAND S et al.: Serum cholesterol and osteoarthritis. The baseline examination of the Ulm Osteoarthritis Study. J Rheumatol 1998; 25: 1827-32.
8. TIKU ML, SHAH R, ALLISON GT: Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem 2000; 275: 20069-76.
9. TIKU ML, OUPTA S, DESHMUKH DR: Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants. Free Radic Res 1999; 30: 395-405.
10. HENROTIN YE, BRUCKNER P, PUJOL J-PL: The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003; 11: 747-55.
11. KUME N, KITA T: Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis. Curr Opin Lipidiol 2001; 12: 419-23.
12. WINYARD PG, TATZBER F, ESTERBAUER H, KUS ML, BLAKE DR, MORRIS CJ: Presence of foam cells: Containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1993; 52: 677-80.
13. DAI L, ZHANG Z, WINYARD PG et al.: A modified form of low-density lipoprotein with increased electronegative charge is present in rheumatoid arthritis synovial fluid. Free Radic Biol Med 1997; 22:705-10.
14. AKAGI M, NISHIMURA S, YOSHIDA K, SAWAMURA T, MUNAKATA H, HAMANISHI C: Cyclic tensile stretch load and oxidized low density lipoprotein synergistically induce lectin-like oxidized LDL receptor-1 in cultured bovine chondrocytes, resulting in decreased cell viability and proteoglycan synthesis. J Orthop Res 2006; 24: 1782-90.
15. SAWAMURA T, KUME N, AOYAMA T et al.: An endothelial receptor for oxidized low-density lipoprotein. Nature 1997; 386: 73-7.
16. NAKAGAWA T, AKAGI M, HOSHIKAWA H et al.: Lectin-like oxidized low-density lipoprotein receptor 1 mediates leukocyte infiltration and articular cartilage destruction in rat zymosan-induced arthritis. Arthritis Rheum 2002; 46: 2486-94.
17. NAKAGAWA T, YASUDA T, HOSHIKAWA H et al.: LOX-1 expressed in cultured rat chondrocytes mediates oxidized LDL-induced cell death - the possible role of dephosphorylation of Akt. Biochem Biophys Res Commun 2002; 299: 91-7.
18. NISHIMURA S, AKAGI M, YOSHIDA K et al.: Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor 1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) resulting in the activation of NF-κB. Osteoarthritis Cartilage 2004; 12: 568-76.
19. KAKINUMA T, YASUDA T, NAKAGAWA T et al.: Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage. Arthritis Rheum 2004; 50: 3495-503.
20. AKAGI M, KANATA S, MORI S, ITABE H, SAWAMURA T, HAMANISHI C: Possible involvement of the oxidized low-density lipoprotein receptor-1 system in the pathogenesis and progression of human osteoarthritis. Osteoarthritis Cartilage 2006; ahead of print.
21. MANKIN HJ, DORFMAN H, LIPPIELLO L, ZARINS A: Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. J Bone Joint Surg 1971; 53A: 523-37.
22. COLE AA, KUETTNER KE: Molecular basis for differences between human joints. Cell Mol Life Sci 2002; 59: 19-26.
23. KELLGREN JH, LAWRENCE JS: Radiological assessment of osteoarthritis. Ann Rheum Dis 1957; 16: 494-501.
24. KELLGREN JH, JEFFREY MR, BALL L: The epidemiology of chronic rheumatism. In: Atlas of Standard Radiographs of Arthritis. Oxford, Blackwell Scientific Publications, 1963.
25. SINGH G, MILLER JD, LEE FH et al.: Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the third National Health and Nutrition Examination Survey. Am J Manag Care 2002; 8 (15 Suppl.): S428-430.
26. CERHAN JR, WALLACE RB, EL-KHOURY GY et al.: Decreased survival with increasing prevalence of full body, radiographically defined osteoarthritis in women. Am J Epidemiol 1995; 141: 225-34.
27. HAARA MM, MANNINEN P, KRÖGER H et al.: Osteoarthritis of the finger joints in Finns aged 30 or over: Prevalence, determinants, and association with mortality. Ann Rheum Dis 2003; 62: 151-8.
28. CONAGHAN PG, VANHARANTA H, DIEEPE PA: Is progressive osteoardiritis an atheromatous vascular disease? Ann Rheum Dis 2005; 64: 1539-41.
29. MURASE T, KUME N, KORENAGA R et al.: Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 1998; 83: 328-33.
30. AOYAMA T, FUJIWARA H, MASAKI T, SAWAMURA T: Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylocholine in cultured endothelial cells. J Mol Cell Cardiol 1999; 31: 2101-14.
31. CHEN M, MASAKI T, SAWAMURA T: LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: Implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 2002; 95: 89-100.
32. STEINBERG D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272: 20963-6.
33. PARHAMI F, TINTUT Y, PATEL JK, MODY N, HEMMAT A, DEMER LL: Regulation of vascular calcification in atherosclerosis. Z Kardiol 2001; 90 (Suppl. 3): III27-III30.
34. WANG Y, PRENTICE LF, VITETTA L, WLUKA AE, CICUTTINI FM: The effect of nutritional supplements on osteoarthrilis. Alter Med Rev 2004; 9: 275-93.
35. MOBASBERI A, VANNUCCI SJ, BONDY CA et al.: Glucose transport and metabolism in chondrocytes: A key to understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis. Histol Histopathol 2002; 17: 1239-67.
36. MCNUTLY AL, STABLER TV, VAIL TP, MCDANIEL GE, KRAUS VB: Dehydroascorbate transport in human chondrocytes is regulated by hypoxia and is a physiologically relevant source of ascorbic acid in the joint. Arthritis Rheum 2005; 52: 2676-85.
37. CLARK AG, ROHRBAUGH AL, OTTERNESS I, KRAUS VB: The effects of ascorbic acid on cartilage metabolism in guinea pig articular cartilage explants. Matrix Biol 2002; 21: 175-84.
38. MCALINDON TE, JACQUES P, ZHANG Y: Do anti-oxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 1996; 39: 648-56.
39. SCHWARTZ ER, OH WH, LEVEILLE CR: Experimentally induced osteoarthritis in guinea pigs: Metabolic responses in articular cartilage to developing pathology. Arthritis Rheum 1981: 24: 1345-55.
40. MEACOCK SC, BODMER JL, BILLINGHAM ME: Experimental osteoarthritis in guinea-pigs. J Exp Pathol (Oxford) 1990; 71: 279-93.
41. KURZ B, JOST B, SCHONKE M: Dietary vitamins and selenium diminish the development of mechanically induced osteoarthritis and increase the expression of anti-oxidative enzymes in the knee joint of STR/1N mice. Osteoarthritis Cartilage 2002; 10: 119-26.
42. WANG Y, CICUTTINI FM, VITETTA L, WLUKA AE: What effect do dietary anti-oxidants have on the symptoms and structural progression of knee osteoarthritis over two years? Clin Exp Rheumatol 2006; 24: 213-14.